 |
| image source: NetBio |
Jacob Goodwin
Government Security News
The U.S. Army announced on July 22 that it is willing to license an invention holding a U.S. patent that can help diagnose exposure to a variety of toxic agents – perhaps including Anthrax, Brucella, Plague, Botulinum, Cholera and others – by measuring distinct patterns in the levels of expression of specific genes.
The Army said it would offer an exclusive, non-exclusive or partially-exclusive license to U.S. patent number 6,316,197, which was filed by inventors, Rina Das, Marti Jett and Chanaka Mendis, in February 2000 and formally issued on November 13, 2001.
RELATED ACTIVIST POST ARTICLE:
How Close Are We to a Nanotechnology-Based Surveillance State?
Be the first to comment on "U.S. Army ready to license technology that can diagnose exposure to toxic agents"